In clinical studies targeting elderly populations, Roche's data on Tamiflu were "substantially better," notes Dietz. In addition, Gilead/Roche's pill formulation offers a significant advantage in ...

Not a substitute for annual influenza vaccination. Consider available information on influenza drug susceptibility patterns and treatment effects when deciding whether to use. Not recommended for ...

Sanofi has made a bold play to bolster its consumer health business, licensing non-prescription rights to Roche’s influenza drug Tamiflu – even though there’s no guarantee it will be ...

But we have the product available in our stock .” Tamiflu capsules have been approved by the US Food and Drug Administration for the treatment of uncomplicated influenza in patients one year and ...